ESOPMay 12, 2026, 01:57 PM
Genmab Increases Share Capital by 2,346 Shares; Raises DKK 3.0M
AI Summary
Genmab A/S announced a capital increase of 2,346 shares following the exercise of employee warrants. This transaction generated approximately DKK 3.0 million in proceeds for the company and represents about 0.004% of the total share capital. The new shares are ordinary, freely transferable, and will be listed on Nasdaq Copenhagen after registration, bringing the total nominal share capital to DKK 62,353,067.
Key Highlights
- Share capital increased by 2,346 shares due to the exercise of employee warrants.
- The company received approximately DKK 3.0 million in proceeds from the warrant exercise.
- The capital increase corresponds to approximately 0.004% of Genmab's existing share capital.
- The new shares are ordinary shares, freely transferable, and grant rights to dividends from subscription.
- The total nominal value of Genmab's share capital after the increase is DKK 62,353,067, consisting of 62,353,067 shares.
- Shares were subscribed at DKK 1,147.50 (908 shares), DKK 1,334.50 (759 shares), and DKK 1,362.50 (679 shares).
Price Impact
More from GMAB